Company intelligence / Profile preview

Trident Lifeline

Surat, Gujarat, Indiatridentlifeline.com ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

Trident Lifeline has a commercial portfolio of pharmaceutical and nutraceutical products distributed across more than 25 countries. The company reported strong revenue growth with INR 467 million in revenue for the year ending March 2024. It has an alliance with NIPER-Ahmedabad for technology transfer of vorinostat used in cutaneous T-cell lymphoma treatment. No clinical trial data disclosed; focus on manufacturing/exporting finished dosages.

Therapeutic areas: OtherOncologyInfectious Diseases
Modalities: TabletsCapsulesLiquid OralsExternal PreparationsNutraceuticalsInjectablesSmall moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

National Institutes of Pharmaceutical Education and Research–Ahmedabad (NIPER-A) for vorinostat technology transfer

Beyond the preview

Go deeper on Trident Lifeline.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trident Lifeline.

Explore the full profile